Vaxxinity Inc reports results for the quarter ended in June - Earnings Summary

Vaxxinity

09/08/2023 14:43

* Vaxxinity Inc  VAXX.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 15
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vaxxinity Inc's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vaxxinity Inc shares had fallen by 5.2% this quarter and
gained 70.7% so far this year.
    * The company reported a quarterly loss of $13.98 million.
    * Wall Street's median 12-month price target for Vaxxinity
Inc is
$12.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 01:42 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.15          -0.11          Beat
 Mar. 31 2023      -0.16          -0.15          Beat
 Dec. 31 2022      -0.16          -0.16          Met
 Sep. 30 2022      -0.15          -0.15          Met